What is the prevalence of myelofibrosis?

What is the prevalence of myelofibrosis?

Primary myelofibrosis is an uncommon disease, with an annual incidence of approximately 0.5-1.5 cases per 100,000 individuals in the United States. In a review of European data sources, the incidence rate of myelofibrosis ranged from 0.1 to 1 cases per 100,000 per year.

How many people have myelofibrosis in the world?

Primary myelofibrosis is a rare chronic disorder diagnosed in an estimated 1 per 100,000 population. It can occur at any age but is usually diagnosed later in life, between the ages of 60 and 70 years. The cause of primary myelofibrosis remains largely unknown.

What is the life expectancy of someone with myelofibrosis?

Life expectancy in PMF Primary myelofibrosis, also known as idiopathic myelofibrosis or myelofibrosis with myeloid metaplasia, is a rare disease19, 20 usually affecting elderly people. Median survival ranges from 4 to 5.5 years in modern series6, 7, 8, 9, 10, 11, 12, 13, 14 (Figure 1).

Does myelofibrosis run in families?

In the majority of cases, myelofibrosis is not inherited genetically — you cannot pass the disease on to your children or inherit it from your parents (although some families do demonstrate a clear predisposition).

How many people have myelofibrosis in us?

Prevalence and demographics MF is a rare disease, with a prevalence of 16,000 to 18,500 patients in the United States. Although MF can occur at any age, the median age at diagnosis ranges from 60 to 67 years. The disease affects both men and women.

What is primary myelofibrosis?

Primary myelofibrosis (PMF) is a rare bone marrow disorder that is characterized by abnormalities in blood cell production (hematopoiesis) and scarring (formation of fibrous tissue) within the bone marrow. Bone marrow is the soft, spongy tissue that fills the center of most bones.

Can myelofibrosis be reversed?

There are currently no medications that cure myelofibrosis. Allogeneic hematopoietic stem cell transplantation is the only treatment that may cure MF or significantly prolong the survival of people with MF.

Can myelofibrosis go into remission?

In the case of progression to AML, the only chance of long-term survival is to get patients to remission so that they can undergo allogeneic hematopoietic cell transplantation. New therapeutic approaches are needed to achieve better outcomes in patients with advanced myelofibrosis when they progress on ruxolitinib.

Is myelofibrosis a rare disease?

Is myelofibrosis curable?

There is no drug therapy that can cure MF. The only potential cure for MF is allogeneic stem cell transplantation. But this procedure is risky for older patients and those with other health problems. Because MF primarily affects older adults, a stem cell transplantation is not a treatment option for most MF patients.

What is blast phase myelofibrosis?

Myelofibrosis (MF) is a clonal stem cell disorder with the potential to transform to acute leukemia, referred to as myelofibrosis in blast phase (MF-BP). The outcome of patients with MF-BP is grave with a median survival of only 2.7 months.

How often does myelofibrosis occur in the world?

According to the latest data, the estimated incidence of myelofibrosis (MF) is 0.1-1.0 per 100,000 worldwide. There are great variations in reported prevalence ranging from 0.5 to 2.7 per 100,000 in Europe and from 4 to 6 per 100,000 in the United States. 13

Is the Nord physician guide for primary myelofibrosis free?

If you have questions about which treatment is right for you, talk to your healthcare professional. The NORD Physician Guide for Primary myelofibrosis was developed as a free service of the National Organization for Rare Disorders (NORD) and it’s medical advisors.

What is the natural history of myelofibrosis?

Natural history. The clinical course of myelofibrosis (MF) is highly heterogeneous, and the disease can last from months to decades without distinct stages or clear progression. 7 As the disease evolves, all patients become symptomatic due to marrow failure, increasing splenomegaly causing abdominal symptoms and early satiety,…

Where can I find information on primary myelofibrosis?

MedlinePlus was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic. MedlinePlus Genetics contains information on Primary myelofibrosis. This website is maintained by the National Library of Medicine.